Ovid Therapeutics
OVID
$3.07
Share price
0.33%
Change (1 day)
-14.72%
Change (1 year)
Categories
EPS for Ovid Therapeutics (OVID)
EPS in 2023 (TTM): -$0.70
According to Ovid Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.70. In 2022 the company made an earnings per share (EPS) of -$0.77 a decrease over its 2021 EPS that were of $1.77.
EPS history for Ovid Therapeutics from 2016 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.70 | -9.09% |
| 2022 | -$0.77 | -143.5% |
| 2021 | $1.77 | -226.43% |
| 2020 | -$1.40 | -11.39% |
| 2019 | -$1.58 | -25.47% |
| 2018 | -$2.12 | -23.94% |
| 2017 | -$2.79 | 143.74% |
| 2016 | -$1.14 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 211.43% | 🇺🇸 USA |